MDxHealth reported revenue of $0.03B and net income of -$0.01B for the quarter ended Jun 2026, down 39.5% year over year. This income statement covers 22 quarters of results from Dec 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Dec2020 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | ||||||||||||||||||||||
| Revenue | 0.01B | 0.01B | -0.01B | 0.01B | 0.01B | 0.01B | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B | 0.04B | 0.08B | 0.03B | 0.03B | 0.03B | |||
| Cost of RevenueCost of Rev | 0.00B | 0.00B | -0.00B | 0.00B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.03B | 0.01B | 0.01B | 0.01B | |||
| Gross Profit | 0.00B | 0.00B | -0.00B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.02B | 0.02B | 0.03B | 0.05B | 0.02B | 0.02B | 0.02B | |||
| Operating items | ||||||||||||||||||||||
| Amortization - Intangibles | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | |||||||
| Research & DevelopmentR&D | -0.00B | -0.00B | -0.00B | -3.58B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.01B | -0.00B | -0.00B | -0.00B | ||
| Selling, General & AdministrativeSG&A | -0.00B | -0.00B | -9.63B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.02B | -0.01B | -0.01B | -0.01B | |||
| Restructuring CostsRestructuring | 0.00B | |||||||||||||||||||||
| Other Operating ExpensesOther Opex | -0.00B | 0.00B | 0.27B | -0.00B | 0.00B | -0.00B | 0.00B | 0.00B | 0.00B | 0.00B | -0.00B | 0.00B | -0.00B | -0.00B | 0.00B | 0.00B | 0.00B | -0.00B | -0.00B | |||
| Operating ExpensesOpex | -0.01B | -0.01B | -0.01B | -0.02B | -0.02B | -0.02B | -0.02B | -0.02B | -0.02B | -0.02B | -0.02B | -0.02B | -0.02B | -0.02B | -0.04B | -0.06B | -0.02B | -0.02B | -0.02B | |||
| Operating IncomeOp. Inc | -0.01B | -0.01B | 0.01B | -0.01B | -0.01B | -0.01B | -0.02B | -0.00B | -0.01B | -0.01B | -0.01B | -0.01B | -0.00B | -0.00B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | |||
| EBIT | -0.01B | -0.01B | 0.01B | -0.01B | -0.01B | -0.01B | -0.02B | -0.00B | -0.01B | -0.01B | -0.01B | -0.01B | -0.00B | -0.00B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | |||
| Non-operating items | ||||||||||||||||||||||
| Non Operating Interest Expenses | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.01B | -0.00B | -0.00B | -0.00B | -0.00B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | ||||||
| Interest & Investment IncomeInt & Inv Inc | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.01B | 0.00B | |||||
| Other Non Operating IncomeOther Non Op Inc. | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | |||||||||||||||
| Net income details | ||||||||||||||||||||||
| EBT | -0.01B | -0.01B | -18.09B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.02B | -0.02B | -0.01B | -0.01B | -0.01B | |||
| Tax ProvisionsTaxes | -0.00B | 0.00B | -0.00B | -0.00B | -0.00B | -0.00B | 0.00B | 0.00B | 0.00B | |||||||||||||
| Profit After TaxPAT | 13.28B | -0.01B | -0.01B | 18.11B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.02B | -0.02B | -0.01B | -0.01B | -0.01B | ||
| Income from Non-Controlling InterestsInc. Minority | -0.12B | 0.00B | 0.59B | -0.59B | 0.00B | -0.00B | ||||||||||||||||
| Income from Continuing OperationsIncome (Continuing) | -0.01B | -0.01B | -18.09B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.02B | -0.03B | -0.01B | -0.01B | -0.01B | |||
| Income from Discontinued OperationsIncome (Discontinued) | -0.00B | -0.00B | ||||||||||||||||||||
| Consolidated Net IncomeConsol Net Inc. | -0.01B | -0.01B | -18.09B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.02B | -0.03B | -0.01B | -0.01B | -0.01B | |||||||
| Income towards Parent CompanyParent Net Inc | -0.01B | -0.01B | 18.11B | -0.01B | -0.01B | 0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | 0.01B | -0.02B | -0.02B | -0.01B | 0.01B | -0.01B | |||
| Net Income towards Common StockholdersNet Income | -0.01B | -0.01B | 18.11B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | 0.01B | -0.02B | -0.02B | -0.01B | 0.01B | -0.01B | |||||||
| Additional items | ||||||||||||||||||||||
| EPS (Basic) | -0.09 | -0.07 | 148.54 | -0.11 | -0.08 | -0.07 | -0.06 | -0.44 | -0.43 | 0.28 | -0.50 | -0.75 | -0.18 | 0.18 | -0.23 | |||||||
| EPS (Diluted) | -0.09 | -0.07 | 148.54 | -0.11 | -0.08 | -0.07 | -0.06 | -0.44 | -0.43 | 0.28 | -0.50 | -0.75 | -0.18 | 0.18 | -0.23 | |||||||
| Shares Outstanding | 0.08B | 0.12B | 0.12B | 0.12B | 0.12B | 0.16B | 0.16B | 0.16B | 0.16B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.05B | 0.05B | 0.05B | ||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 0.08B | 0.12B | 0.12B | 0.12B | 0.12B | 0.16B | 0.16B | 0.16B | 0.16B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.05B | 0.05B | 0.05B | ||
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 0.12B | 0.16B | 0.03B | 0.03B | 0.05B | |||||||||||||||||
| EBITDA | -0.01B | -0.01B | 0.01B | -0.01B | -0.01B | -0.01B | -0.02B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | 0.00B | 0.00B | -0.00B | -0.00B | -0.00B | |||
| Interest ExpensesInt Expense | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.01B | -0.00B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | ||||||||||
| Tax Rate | 0.01% | -8.28% | 1.04% | 3.17% | 0.71% | 1.51% | -2.51% | -1.15% | -14.97% |